Acumen Medical Inc is categorized under Business Consultants in Mountain View, CA and active since 2003.
Acumen Medical Inc was established in 2003, and today employs 1 to 4, earning $5.000.000 to $9.999.999 per year. This is a Business Consultants business, which does work in the B2B market, and is classified as a Business Consultants, under code number 3391120 by the NAICS.
If you are seeking more information, feel free to contact Steve Leefang at the company’s single location by writing to 2109 Landings Drive, Mountain View, California CA 94043 or by phoning (408) 530-1810. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Acumen Medical Inc |
| Contact Person: | Steve Leefang |
| Address: | 2109 Landings Drive, Mountain View, California 94043 |
| Phone Number: | (408) 530-1810 |
| Website Address: | acumen-medical.com |
| Annual Revenue (USD): | $5.000.000 to $9.999.999 |
| Founded: | 2003 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Business Consultants |
| SIC Code: | 8748 |
| NAICS Code: | 3391120 |
| Share This Business: |
Acumen Medical Inc was started in 2003 to provide professional Business Consultants under the SIC code 8748 and NAICS code 3391120. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $5.000.000 to $9.999.999 per annum.
Feel free to contact Steve Leefang for inquiries that concern Acumen Medical Inc by calling the company number (408) 530-1810, as your correspondence is most welcome. Additionally, the physical location of the single location of Acumen Medical Inc can be found at the coordinates 37.42,-122.09032 as well as the street address 2109 Landings Drive in Mountain View, California 94043.
For its online presence, you may visit Acumen Medical Inc’s website at acumen-medical.com and engage with its social media outlets through on Twitter and on Facebook.